Mary Healy

Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571

Wenlan Wang, Mary Healy, Martin Sattler et al. · Oncogene · 2000 · 236 citations

Medicine, Oncology, Pharmacology +14

Celiac Disease and the Transition from Childhood to Adulthood: A 28-Year Follow-Up

Clare O’Leary, Peter Wieneke, Mary Healy et al. · The American Journal of Gastroenterology · 2004 · 90 citations

Agriculture, Nutritional Sciences, Pediatrics +16

Phase I study of ceritinib in pediatric patients (Pts) with malignancies harboring a genetic alteration in ALK (ALK+): Safety, pharmacokinetic (PK), and efficacy results.

Birgit Geoerger, Johannes H. Schulte, C. Michel Zwaan et al. · Journal of Clinical Oncology · 2015 · 35 citations

Medicine, Oncology, Pharmacology +17

Clinical activity of BLU-285 in advanced gastrointestinal stromal tumor (GIST).

Michael C. Heinrich, Robin L. Jones, Margaret von Mehren et al. · Journal of Clinical Oncology · 2017 · 20 citations

Medicine, Oncology, Pharmacology +15

Preliminary Safety and Clinical Activity in a Phase 1 Study of Blu-285, a Potent, Highly-Selective Inhibitor of KIT D816V in Advanced Systemic Mastocytosis (SM)

Mark W. Drummond, Daniel J. DeAngelo, Michael W. Deininger et al. · Blood · 2016 · 14 citations

Medicine, Immunology, Pharmacology +12